Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lindgren

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 11, 2005
Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter Lindgren, Martin Buxton, Thomas Kahan, et al.
Diabetes/Metabolism Research and Reviews|January 30, 2018
Association between sociodemographic determinants and health outcomes in individuals with type 2 diabetes in SwedenBettina Julin, Carl Willers, Janeth Leksell, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 30, 2019
Postmortem magnetic resonance imaging vs autopsy of second trimester fetuses terminated due to anomaliesAnna Hellkvist, Johan Wikström, Ajlana Mulic-Lutvica, et al.
Cardiovascular Ultrasound|August 15, 2020
Fetal cardiac function at intrauterine transfusion assessed by automated analysis of color tissue Doppler recordingsLotta Herling, Jonas Johnson, Kjerstin Ferm-Widlund, et al.
International Journal of Technology Assessment in Health Care|May 12, 2007
Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effectivePeter Lindgren, Jaana Lindström, Jaakko Tuomilehto, et al.
Pharmacoeconomics|April 10, 2009
The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1Peter Lindgren, Martin Buxton, Thomas Kahan, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 7, 2021
Effect of second-trimester sonographic cervical length on the risk of spontaneous preterm delivery in different risk groups: A prospective observational multicenter studyTove Wikström, Henrik Hagberg, Bo Jacobsson, et al.
Neuromuscular Disorders : NMD|October 21, 2015
Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)Erik Landfeldt, Anna Mayhew, Michelle Eagle, et al.
Neuromuscular Disorders : NMD|April 19, 2016
Corrigendum to "Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)" [Neuromuscular Disorders 25 (2015) 937-944]Erik Landfeldt, Anna Mayhew, Michelle Eagle, et al.
Pharmacoeconomics - Open|December 17, 2024
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological ConsiderationsPraveen Thokala, Henrique Duarte, Stuart Wright, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 11, 2005
Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter Lindgren, Martin Buxton, Thomas Kahan, et al.
Diabetes/Metabolism Research and Reviews|January 30, 2018
Association between sociodemographic determinants and health outcomes in individuals with type 2 diabetes in SwedenBettina Julin, Carl Willers, Janeth Leksell, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 30, 2019
Postmortem magnetic resonance imaging vs autopsy of second trimester fetuses terminated due to anomaliesAnna Hellkvist, Johan Wikström, Ajlana Mulic-Lutvica, et al.
Cardiovascular Ultrasound|August 15, 2020
Fetal cardiac function at intrauterine transfusion assessed by automated analysis of color tissue Doppler recordingsLotta Herling, Jonas Johnson, Kjerstin Ferm-Widlund, et al.
International Journal of Technology Assessment in Health Care|May 12, 2007
Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effectivePeter Lindgren, Jaana Lindström, Jaakko Tuomilehto, et al.
Pharmacoeconomics|April 10, 2009
The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1Peter Lindgren, Martin Buxton, Thomas Kahan, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 7, 2021
Effect of second-trimester sonographic cervical length on the risk of spontaneous preterm delivery in different risk groups: A prospective observational multicenter studyTove Wikström, Henrik Hagberg, Bo Jacobsson, et al.
Neuromuscular Disorders : NMD|October 21, 2015
Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)Erik Landfeldt, Anna Mayhew, Michelle Eagle, et al.
Neuromuscular Disorders : NMD|April 19, 2016
Corrigendum to "Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)" [Neuromuscular Disorders 25 (2015) 937-944]Erik Landfeldt, Anna Mayhew, Michelle Eagle, et al.
Pharmacoeconomics - Open|December 17, 2024
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological ConsiderationsPraveen Thokala, Henrique Duarte, Stuart Wright, et al.
Pageof 17